Currently viewing the tag: "U.S. Food and Drug Administration"

The Medical Device Amendments of 1976 (MDA), to the Food, Drug, and Cosmetic Act (FDCA), divide medical devices into three classes according to user risk. Class I devices pose the least risk; Class III devices pose the most. Class I devices are subject to general controls such as labeling requirements. Class II devices are subject to [...]

Continue Reading

With last week’s announcement of the new iPhone 6 and Apple Watch, the tech giant has come under scrutiny from lawmakers, regulators, and the general public. Just one week after Tim Cook, Apple’s chief executive officer, introduced the company’s latest offerings, Apple is seemingly running damage control. This may come as no surprise (to [...]

Continue Reading

It's Not About The Bike

On July 21, 2010 By Nathan McGregor

Despite the supposed secrecy of grand jury proceedings, several media outlets have reported on various aspects of a federal investigation into American cyclist Lance Armstrong, currently competing in what he has said will be his last Tour de France. The seven-time champion has faced an array of obstacles on and off the course [...]

Continue Reading